Lv1
48 积分 2024-03-04 加入
Xalnesiran in Chronic Hepatitis B
13天前
已关闭
Xalnesiran in Chronic Hepatitis B
13天前
已关闭
VAP-1, a Novel Molecule Linked to Endothelial Damage and Kidney Function in Kidney Allograft Recipients
1个月前
已完结
Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease
1个月前
已完结
The preclinical discovery and development of upadacitinib for the treatment of Crohn’s disease
2个月前
已完结
An enhanced bunionectomy model as a potential tool for early decision-making in the development of new analgesics
2个月前
已完结
Prevalence and Incidence of Uveitis: A Systematic Review and Meta-analysis
3个月前
已完结
Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial
4个月前
已完结
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
4个月前
已完结
Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial
4个月前
已完结
皖公网安备34019202002308